Equities Analysts Offer Predictions for ORKA Q1 Earnings
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – HC Wainwright issued their Q1 2026 EPS estimates for shares of Oruka Therapeutics in a report issued on Monday, April 28th. HC Wainwright analyst M. Kapoor anticipates that the company will earn ($0.62) per share for the quarter. HC Wainwright currently has a “Buy” rating and a […]
